SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.
Rinaldi-Carmona M, Barth F, Millan J, Derocq JM, Casellas P, Congy C, Oustric D, Sarran M, Bouaboula M, Calandra B, Portier M, Shire D, Brelière JC, Le Fur GL.
Rinaldi-Carmona M, et al. Among authors: calandra b.
J Pharmacol Exp Ther. 1998 Feb;284(2):644-50.
J Pharmacol Exp Ther. 1998.
PMID: 9454810